PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
Gensco Labs

Press Release

Share      Blog

Receive press releases from Gensco Labs: By Email PDF Version RSS Feeds:

Gensco Labs Announces LiDORx® Copay Program Mobile Platform for Pain Management


Gensco Labs Announces LiDORx® Copay Program Mobile Platform for Pain Management
Miami, FL, August 11, 2015 --(PR.com)-- Text “LIDO to 37500” on your mobile device to receive the benefits of the Program

Gensco Laboratories™ (www.genscolabs.com), A Specialty Pharmaceutical Company, announces a new mobile platform that uses innovative smart phone technology to provide copay assistance and facilitate pain management for patients. Patients are eligible when they enroll in Gensco’s Boundless Savings Program by texting “LIDO” to 37500 on their smart phones.

Chronic pain affects more people than cancer, diabetes, heart attack and stroke combined. The Institute of Medicine estimates there are more than 100 million sufferers in the United States. LiDORx® for pain management is covered by most insurers nationally and includes a mobile copay program. This new technology will incorporate Gensco’s Product LiDORx®. The medication, LiDORx® is a clear, odorless topical anesthetic gel that delivers controlled pain relief as directed by a physician and provides accurate dosing with a 1 pump = 1 dose (0.25 mL). The metered dose technology (MDose™) dispenses the exact amount of the medication needed. It is easy to apply over a 2 inch by 2 inch surface area and works quickly. The onset of action is five to ten minutes. The new LiDORx® Copay program is innovative and valuable. To enroll in the copay program, text “LIDO to 37500” on a mobile device to receive the benefits of the program. LiDORx® is available at most National retail chain pharmacies and patients can save up to $60 per prescription filled. Carlos Alfaras, President and CEO of Gensco Labs says, “As a pharmaceutical manufacturer, we have a responsibility to provide access to safe and effective medications. We recognize the need to assist with the financial burden as our duty.”

LiDORx® is indicated for pain and can be applied directly at the site. It can be accessed via text by texting “LIDO” to 37500 on your mobile device*, online at www.genscolabs.com/mobile or by printing a copay savings card at www.genscolabs.com/mobile and taking it to your local pharmacist. *Terms and conditions apply minimum $20 copay. Messaging and data rates may apply.

About Gensco Labs
Gensco Laboratories is a pharmaceutical manufacturer focusing on the research, development, and marketing of transdermal prescription medications. As an innovator of pharmaceutical products and the development of patented drug delivery systems, we are dedicated to the continual pursuit of novel and effective therapies that improve health. For more information visit our website at www.genscolabs.com

Media Contact: Randi Press | Patricia Beitler

Gensco Labs O: 855.743.6726 - press@genscolabs.com
Contact Information
Gensco Labs
Patricia Beitler
305-503-3055
Contact
genscolabs.com

Click here to view the list of recent Press Releases from Gensco Labs
Promote Your Business